Here, the authors report a phase 2 clinical trial investigating immune activation and efficacy of neoadjuvant pembrolizumab administered after one cycle of neo-adjuvant chemotherapy in patients ...

Liu, T. and Liu, J. (2025) Translating Evidence for Clinical Practice in the Management of Psychological Distress in Patients with Advanced Oncology. Journal of Biosciences and Medicines, 13, 128-140.

LibreClinica is the community driven successor of OpenClinica. It is an open source clinical trial software for Electronic Data Capture (EDC) Clinical Data Management (CDM).

The first patient has been dosed in a phase 1/2 clinical trial evaluating KSQ-004EX in solid tumors including melanoma, non-small cell lung cancer (NSCLC), head and neck squamous cell carcinoma (HNSCC ...

YANTAI, China, April 8, 2025 /PRNewswire/ -- On April 8, 2025 (UTC-7), impressive results of the Phase 3 clinical trial (NCT05737160) evaluating the efficacy and safety of Telitacicept (synonym ...

Northwell Health is conducting a clinical trial to address treatment-resistant depression using similar technology used to treat neurological diseases like Parkinson’s in an effort to seek ...

BUSAN, South Korea--(BUSINESS WIRE)--#BiopharmaceuticalCompany--NexThera Co., Ltd. (CEO:SaeGwang Park) announced on April 9th that it has completed the first patient enrollment for its Phase 1/2a ...

Multi-center trial will assess safety and efficacy of ASI-02 contrast ... portfolio of products to enhance the use of ultrasound imaging, improve efficiency and clinical outcomes. The Company's ...

Lizella is planning to submit an investigational new drug application for a Phase IIb trial in late 2025. Credit: MacroEcon/Shutterstock ... term and believe this dataset will be critical in informing ...

Credit: Getty Images In a phase 3 clinical trial, researchers assessed the efficacy and safety of inebilizumab in patients with generalized myasthenia gravis. At Week 26, compared to the placebo ...

Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called disability accrual. Current disease-modifying therapies for multiple ...

Sir Keir Starmer has pledged to slash the number of days it takes to set up a clinical trial from “over 250” to 150, in a bid to strengthen the UK’s medical sciences industry. The Prime ...